Funding news
Grüns logo

Grüns Raises $35M Series B to Revolutionize Health with Snackable Greens!

Recently funded · $35.0M Series bHealth and Wellness

Get the full Grüns company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Grüns is thrilled to announce that we have successfully raised $35,000,000 in a new funding round, marking a significant milestone in our journey to revolutionize the health and wellness industry. Our innovative approach is built on the belief that health should be a snack—imagine a world where broccoli tastes like chocolate, kale like candy, and greens supplements resemble your favorite gummy bears. While we haven’t quite mastered the art of choco broccoli yet, our breakthrough formulation has transformed overpriced, chalky powders into snackable and utterly delicious products that combine the natural sweetness of fruits with the essential nutrients your body craves. With 60 ingredients spanning 8 core nutrient categories, Grüns is designed to offer comprehensive health support that can replace multiple conventional health products, making it easier than ever to stay nourished and energized.

The new funding will be instrumental in accelerating our innovative research and development initiatives, expanding our product line, and enhancing our distribution channels to reach a wider audience. We are committed to further optimizing our recipes and incorporating novel ingredients that continue to support various health benefits, ensuring that every bite you take is a step toward a healthier lifestyle. Additionally, these funds will help us invest in cutting-edge marketing and educational initiatives to spread awareness about the benefits of incorporating Grüns into your daily routine. We are excited about the future and the opportunities that lie ahead, and we look forward to pioneering a new era in health and nutrition with the continued support of our investors, partners, and loyal customers.

Other recently funded companies

View all

Other recent Series b rounds

Companies that recently closed a Series b round.

#CompanyAmount
1
Isomorphic Labs logo

Isomorphic Labs

United Kingdom

$2.1B
2
Invert Robotics logo

Invert Robotics

Ireland

$2.7M
3
Catch Co. logo

Catch Co.

United States

$38.0M
4
Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc.

United States

$60.0M
5
Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc.

United States

$21.0M